Aptinyx (NASDAQ: APTX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Aptinyx (NASDAQ: APTX) through any online brokerage.
The latest price target for Aptinyx (NASDAQ: APTX) was reported by Piper Sandler on Thursday, May 19, 2022. The analyst firm set a price target for 6.00 expecting APTX to rise to within 12 months (a possible 975.46% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Aptinyx (NASDAQ: APTX) is $0.5579 last updated June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Aptinyx.
Aptinyx’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Aptinyx.
Aptinyx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.